Does generic substitution always make sense?

Journal of Medical Economics

Volumn 11, Issue 3, 2008, Pages 547-553

  Greenberg, Paul E ^a  

^a ANALYSIS GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; ATORVASTATIN; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; GENERIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LANSOPRAZOLE; LEVOTHYROXINE SODIUM; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIMVASTATIN; TETRAHYDROLIPSTATIN; WARFARIN;

BIOEQUIVALENCE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEARTBURN; HUMAN; PATENT; PHARMACEUTICAL CARE; PHARMACIST; PLACEBO EFFECT; PRESCRIPTION; QUALITY CONTROL;

COST-BENEFIT ANALYSIS; DRUGS, GENERIC; FEES, PHARMACEUTICAL; HEALTH EXPENDITURES; HUMANS; THERAPEUTIC EQUIVALENCY;

EID: 55049140244     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990802371075     Document Type: Editorial

References (9)

1. IMS National Sales Perspective, Moving Annual Total, 2007. Available at: http://www.imshealth.com/portal/site/imshealth/ menuitem.a46c6d4df3db4b3d88f611019418c22a/ ?vgnextoid=280c1d3be7a29110VgnVCM10000071812ca2RCRD&vgnextchannel= 41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default
2. FDA: Generic Competition and Drug Prices. Available at: http://www.fda.gov/cder/ogd/generic_competition.htm
3. Generic Pharmaceutical Association Annual Report 2008. Available at: http://www.gphaonline-org/AM/Template.cfm?Section= Resources&TEMPLATE=/CM/ContentDisplay.cfm&CONTENTID=4201
4. Generic Drug Review. US Pharm 2008; 33](6): 30-34.
5. Research Letter to JAMA, Journal of the American Medical Association (March 5, 2008).
6. LeLorier J, Duh MS, Paradis PE et al. Clinical consequences of generic substitution of lamnotrigine for patients with epilepsy. Neurology 2008; 70: 2179-2186.
7. Wu EQ, Yang E, Greenberg P, Erder MH, Buessing M. Health care costs and resource use in patients with major depressive disorder: a comparison between escitalopram and other antidepressants. International Society for Pharmacoeconomics & Outcomes Research (ISPOR), 2007.
8. Wu EQ, Yang E, Greenberg P, Erder MH, Buessing M. Comparison of health care costs and hospitalization days of elderly major depressive disorder patients treated with escitalopram and other antidepressants. International Society for Pharmacoeconomics & Outcomes Research (ISPOR), 2007.
9. Zachs Research Reports, June 18, 2008.